Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 14:17:40 UTC |
---|
Update Date | 2022-03-07 02:49:13 UTC |
---|
HMDB ID | HMDB0002183 |
---|
Secondary Accession Numbers | - HMDB0062579
- HMDB02183
- HMDB62579
|
---|
Metabolite Identification |
---|
Common Name | Docosahexaenoic acid |
---|
Description | Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis- double bonds with the first double bond located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease (Wikipedia ). Docosahexaenoic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. |
---|
Structure | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- |
---|
Synonyms | Value | Source |
---|
(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid | ChEBI | 22:6(N-3) | ChEBI | 22:6-4, 7,10,13,16,19 | ChEBI | 4,7,10,13,16,19-Docosahexaenoic acid | ChEBI | all-cis-4,7,10,13,16,19-Docosahexaenoic acid | ChEBI | all-cis-DHA | ChEBI | Cervonic acid | ChEBI | DHA | ChEBI | Doconexent | ChEBI | DOCOSA-4,7,10,13,16,19-hexaenoIC ACID | ChEBI | Docosahexaenoate | Kegg | 4Z,7Z,10Z,13Z,16Z,19Z-Docosahexaenoic acid | Kegg | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid | Kegg | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoate | Generator | 4,7,10,13,16,19-Docosahexaenoate | Generator | all-cis-4,7,10,13,16,19-Docosahexaenoate | Generator | Cervonate | Generator | DOCOSA-4,7,10,13,16,19-hexaenoate | Generator | 4Z,7Z,10Z,13Z,16Z,19Z-Docosahexaenoate | Generator | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoate | Generator | all-Z-Docosahexaenoate | HMDB | all-Z-Docosahexaenoic acid | HMDB | cis-4,7,10,13,16,19-Docosahexanoate | HMDB | cis-4,7,10,13,16,19-Docosahexanoic acid | HMDB | Doconexento | HMDB | Doconexentum | HMDB | Doxonexent | HMDB | Acids, docosahexaenoic | HMDB | Acids, docosahexenoic | HMDB | Docosahexaenoic acid, 4,7,10,13,16,19-(all-Z-isomer) | HMDB | Docosahexaenoic acid (all-Z isomer) | HMDB | Docosahexaenoic acid, 4,7,10,13,16,19-isomer | HMDB | Efalex | HMDB | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-Docosahexaenoic acid | HMDB | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexenoic acid | HMDB | (all-Z)-4,7,10,13,16,19-Docosahexaenoic acid | HMDB | 4-cis,7-cis,10-cis,13-cis,16-cis,19-cis-Docosahexaenoic acid | HMDB | FA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | HMDB | FA(22:6n3) | HMDB | delta4,7,10,13,16,19-Docosahexaenoic acid | HMDB | Δ4,7,10,13,16,19-docosahexaenoic acid | HMDB | Docosahexaenoic acid | HMDB | Choline docosahexaenoate | HMDB | Choline docosahexaenoic acid | HMDB | Docosahexaenoylcholine | HMDB |
|
---|
Chemical Formula | C22H32O2 |
---|
Average Molecular Weight | 328.4883 |
---|
Monoisotopic Molecular Weight | 328.240230268 |
---|
IUPAC Name | (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid |
---|
Traditional Name | docosahexaenoic acid |
---|
CAS Registry Number | 6217-54-5 |
---|
SMILES | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O |
---|
InChI Identifier | InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- |
---|
InChI Key | MBMBGCFOFBJSGT-KUBAVDMBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as very long-chain fatty acids. These are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Fatty acids and conjugates |
---|
Direct Parent | Very long-chain fatty acids |
---|
Alternative Parents | |
---|
Substituents | - Very long-chain fatty acid
- Unsaturated fatty acid
- Straight chain fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Docosahexaenoic acid GC-MS (1 TMS) | splash10-004l-9800000000-86f34228f9e92b6da2c6 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Docosahexaenoic acid GC-MS (Non-derivatized) | splash10-004l-9800000000-86f34228f9e92b6da2c6 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Docosahexaenoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0690-5590000000-145821d84e425eec8f98 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Docosahexaenoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-0079-9363000000-db2668be2bbd1dbdd562 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Docosahexaenoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-002f-9400000000-60bd7bfd4de9015476c7 | 2015-03-01 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid LC-ESI-IT , negative-QTOF | splash10-001i-0190000000-e6566b5aff7cefa4ae5d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid LC-ESI-QQ , negative-QTOF | splash10-004i-0069000000-c76c91e0abd1895adb8b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid LC-ESI-QQ , negative-QTOF | splash10-001r-0069000000-a25e6a700612620a1217 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 35V, Negative-QTOF | splash10-0ab9-9321000000-6b36fbd84ed730000eac | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 35V, Negative-QTOF | splash10-0a4i-9642000000-5ecff42b9082b57b5be6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 35V, Negative-QTOF | splash10-004i-0389000000-737691a3fc2f16b3c59e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 40V, Positive-QTOF | splash10-00l6-9510000000-8e81381f5f447b18e9fc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Positive-QTOF | splash10-004i-0009000000-071caf7af6bdab525160 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Positive-QTOF | splash10-004i-1669000000-4e72cfd5cc68b32bd371 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Negative-QTOF | splash10-0059-1179000000-289993a223b524e7c74f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Negative-QTOF | splash10-004i-0019000000-aa9263466508c9f2e65c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 30V, Negative-QTOF | splash10-004i-7389000000-4e6afa18acb803f01d23 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 35V, Negative-QTOF | splash10-0a4i-9442000000-c452e1856fb3038c7f1e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Positive-QTOF | splash10-004i-1569000000-4e72cfd5cc68b32bd371 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Positive-QTOF | splash10-01t9-0139000000-7f2351e9d6b367bd3e6d | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Positive-QTOF | splash10-001i-3592000000-10365ee2a8e305e24bd4 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 40V, Positive-QTOF | splash10-0ktf-8960000000-6382301474f6f5630982 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Negative-QTOF | splash10-004i-0019000000-f498ba345a6e0d89ae44 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Negative-QTOF | splash10-0059-1069000000-be6f83d34620dceb650e | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 40V, Negative-QTOF | splash10-0a4l-9130000000-abfb63ab3950fe4edf48 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Positive-QTOF | splash10-03fr-1439000000-c5fd83b4d4f8531d17e2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Positive-QTOF | splash10-01q9-3922000000-a59c9fe862e58a93dd03 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 40V, Positive-QTOF | splash10-05o3-7900000000-c8cfc5620efa939690bb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 10V, Negative-QTOF | splash10-004i-0009000000-abcf527af18f1147a0aa | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Docosahexaenoic acid 20V, Negative-QTOF | splash10-056r-1119000000-fbe7758a1c75272194e2 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Brain
- Epidermis
- Erythrocyte
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Pancreas
- Placenta
- Platelet
- Prostate
- Retina
- Skeletal Muscle
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 94.2 +/- 31.3 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 4.66 +/- 3.3 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 90.9 +/- 21.6 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 98.7 +/- 41.0 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 2.3 +/- 1.2 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.9 +/- 0.3 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.777 +/- 0.796 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.990 +/- 0.009 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 128.5 +/- 46.1 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 103.504 +/- 30.442 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 100.460 +/- 24.354 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 66.973 +/- 21.310 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.00347 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.00391 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.00414 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.00461 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 60.885 +/- 12.177 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 154.252 +/- 47.155 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 165.607 +/- 68.496 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 189.352 +/- 70.0177 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 255.260 +/- 75.162 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 420 +/- 110 uM | Adult (>18 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.15 +/- 0.015 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 5.5 +/- 6.3 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 64.7 +/- 39.2 uM | Adult (>18 years old) | Both | Hypertension | | details | Blood | Detected and Quantified | 56.6 +/- 36.7 uM | Adult (>18 years old) | Male | Essential hypertension | | details | Blood | Detected and Quantified | 83.0 +/- 39.0 uM | Adult (>18 years old) | Female | Essential hypertension | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal adenoma | | details | Blood | Detected and Quantified | 20.66 uM | Newborn (0-30 days old) | Female | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 122.36 uM | Infant (0-1 year old) | Male | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 135.43 uM | Newborn (0-30 days old) | Female | Rhizomelic chondrodysplasia punctata | | details | Blood | Detected and Quantified | 144.700-160.300 uM | Children (1-13 years old) | Female | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 64.3 +/- 28.5 uM | Adult (>18 years old) | Not Specified | Isovaleric acidemia | | details | Blood | Detected and Quantified | 146.733 +/- 61.798 uM | Adult (>18 years old) | Both | Depression | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 1.43 +/- 0.3 uM | Adult (>18 years old) | Both | Stroke | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Newborn (0-30 days old) | Not Specified | Premature neonates | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Urine | Detected and Quantified | 4.4 +/- 9.4 umol/mmol creatinine | Adult (>18 years old) | Both | Thyroid cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Hypertension |
---|
- Wang S, Ma A, Song S, Quan Q, Zhao X, Zheng X: Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients. Hypertens Res. 2008 Apr;31(4):623-32. doi: 10.1291/hypres.31.623. [PubMed:18633173 ]
| Essential hypertension |
---|
- Wang S, Ma A, Song S, Quan Q, Zhao X, Zheng X: Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients. Hypertens Res. 2008 Apr;31(4):623-32. doi: 10.1291/hypres.31.623. [PubMed:18633173 ]
| Major depressive disorder |
---|
- Sublette ME, Segal-Isaacson CJ, Cooper TB, Fekri S, Vanegas N, Galfalvy HC, Oquendo MA, Mann JJ: Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder. J Am Diet Assoc. 2011 Jan;111(1):117-123.e1-2. doi: 10.1016/j.jada.2010.10.007. [PubMed:21185973 ]
| Rhizomelic chondrodysplasia punctata |
---|
- Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM: Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [PubMed:9818927 ]
| Isovaleric acidemia |
---|
- Dercksen M, Kulik W, Mienie LJ, Reinecke CJ, Wanders RJ, Duran M: Polyunsaturated fatty acid status in treated isovaleric acidemia patients. Eur J Clin Nutr. 2016 Oct;70(10):1123-1126. doi: 10.1038/ejcn.2016.100. Epub 2016 Jun 22. [PubMed:27329611 ]
| Stroke |
---|
- Pilitsis JG, Coplin WM, O'Regan MH, Wellwood JM, Diaz FG, Fairfax MR, Michael DB, Phillis JW: Measurement of free fatty acids in cerebrospinal fluid from patients with hemorrhagic and ischemic stroke. Brain Res. 2003 Sep 26;985(2):198-201. [PubMed:12967724 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Thyroid cancer |
---|
- Kim KM, Jung BH, Lho DS, Chung WY, Paeng KJ, Chung BC: Alteration of urinary profiles of endogenous steroids and polyunsaturated fatty acids in thyroid cancer. Cancer Lett. 2003 Dec 30;202(2):173-9. [PubMed:14643447 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB03756 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB003003 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 393183 |
---|
KEGG Compound ID | C06429 |
---|
BioCyc ID | CPD-10244 |
---|
BiGG ID | 1586190 |
---|
Wikipedia Link | Docosahexaenoic_acid |
---|
METLIN ID | 3457 |
---|
PubChem Compound | 445580 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28125 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | CRVNC |
---|
MarkerDB ID | MDB00000383 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Wright, Stephen W.; Kuo, Elaine Y.; Corey, E. J. An effective process for the isolation of Docosahexaenoic acid in quantity from cod liver oil. Journal of Organic Chemistry (1987), 52(19), 4399-4401. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003 Jan;166(1):85-93. [PubMed:12482554 ]
- Watanabe A, Saito S, Tsuchida T, Higuchi K, Okita M: Low plasma levels of docosahexaenoic acid in patients with liver cirrhosis and its correction with a polyunsaturated fatty acid-enriched soft oil capsule. Nutrition. 1999 Apr;15(4):284-8. [PubMed:10319360 ]
- Sanders TA: Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr. 2000 Jan;71(1 Suppl):176S-8S. [PubMed:10617968 ]
- Gomez de Segura IA, Valderrabano S, Vazquez I, Vallejo-Cremades MT, Gomez-Garcia L, Sanchez M, de Miguel E: Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat. Eur J Gastroenterol Hepatol. 2004 May;16(5):479-85. [PubMed:15097041 ]
- Shingu T, Karanian JW, Kim HY, Yergey JA, Salem N Jr: Discovery of novel brain lipoxygenase products formed from docosahexaenoic acid (22:6w3). Adv Alcohol Subst Abuse. 1988;7(3-4):235-40. [PubMed:2975919 ]
- Hong S, Tjonahen E, Morgan EL, Lu Y, Serhan CN, Rowley AF: Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 2005 Dec;78(1-4):107-16. Epub 2005 Jun 13. [PubMed:16303609 ]
- Hibbeln JR, Bissette G, Umhau JC, George DT: Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence. Biol Psychiatry. 2004 Dec 1;56(11):895-7. [PubMed:15576068 ]
- Jorgensen MH, Hernell O, Hughes E, Michaelsen KF: Is there a relation between docosahexaenoic acid concentration in mothers' milk and visual development in term infants? J Pediatr Gastroenterol Nutr. 2001 Mar;32(3):293-6. [PubMed:11345178 ]
- Crabtree JT, Gordon MJ, Campbell FM, Dutta-Roy AK: Differential distribution and metabolism of arachidonic acid and docosahexaenoic acid by human placental choriocarcinoma (BeWo) cells. Mol Cell Biochem. 1998 Aug;185(1-2):191-8. [PubMed:9746226 ]
- Gordon N: Nutrition and cognitive function. Brain Dev. 1997 Apr;19(3):165-70. [PubMed:9134186 ]
- Martinez M: Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? Neurology. 1990 Aug;40(8):1292-8. [PubMed:2143272 ]
- Bohles H, Arndt S, Ohlenschlager U, Beeg T, Gebhardt B, Sewell AC: Maternal plasma homocysteine, placenta status and docosahexaenoic acid concentration in erythrocyte phospholipids of the newborn. Eur J Pediatr. 1999 Mar;158(3):243-6. [PubMed:10094448 ]
- Crawford MA, Bloom M, Broadhurst CL, Schmidt WF, Cunnane SC, Galli C, Gehbremeskel K, Linseisen F, Lloyd-Smith J, Parkington J: Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids. 1999;34 Suppl:S39-47. [PubMed:10419087 ]
- Andersson L, Sternby B, Nilsson A: Hydrolysis of phosphatidylethanolamine by human pancreatic phospholipase A2. Effect of bile salts. Scand J Gastroenterol. 1994 Feb;29(2):182-7. [PubMed:8171289 ]
- Brossard N, Croset M, Normand S, Pousin J, Lecerf J, Laville M, Tayot JL, Lagarde M: Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res. 1997 Aug;38(8):1571-82. [PubMed:9300779 ]
- Berry CB, Hayes D, Murphy A, Wiessner M, Rauen T, McBean GJ: Differential modulation of the glutamate transporters GLT1, GLAST and EAAC1 by docosahexaenoic acid. Brain Res. 2005 Mar 10;1037(1-2):123-33. [PubMed:15777760 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|